CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$2.00
52W Range
$1.84 - $896.00
50D Avg
$5.41
200D Avg
$16.24
Market Cap
$2.30M
Avg Vol (3M)
$250.69K
Beta
0.44
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.